Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
D000477:Alkylating Agents / Q000627:therapeutic use; D000577:Amides / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013997:Time Factors; D014508:Urea / Q000627:therapeutic use
D000477:Alkylating Agents; D000577:Amides; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D007093:Imidazoles; D009607:Nitrosourea Compounds; D011687:Purines; D011743:Pyrimidines; D003561:Cytarabine; D014508:Urea; D008727:Methotrexate